Article metrics

Download PDFPDF

600 Post-hoc analysis from two phase I/II NY-ESO-1-TCR T-cell therapy clinical trials in patients with advanced sarcoma (SS or MRCLS) demonstrates response across a range of NY-ESO-1 expression
Free

 

Online download statistics by month:

Online download statistics by month: December 2022 to October 2024

AbstractFullPdf
Dec 20227003
Jan 20233405
Feb 20235203
Mar 202358010
Apr 202340015
May 202352010
Jun 20233604
Jul 20237203
Aug 20233204
Sep 20232003
Oct 20233403
Nov 202342031
Dec 202336029
Jan 20242603
Feb 202444022
Mar 20245207
Apr 202444013
May 20242404
Jun 20242609
Jul 20247204
Aug 20243009
Sep 20242006
Oct 202414012
Total9300212